{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 271,
  "pageCount": 415,
  "prevPage": 270,
  "nextPage": 272,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses direct quotes to expose the insurer's strategy of forcing generic/compounded substitution to save costs.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/271",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-271",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Simple for Blue Shield to force generic substitution; insurers providing initial coverage will eventually why not use generic",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ad-3c43ebc2f876",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.67
      },
      "kind": "quote",
      "text": "...they may get away with it initially, but eventually, people are going to catch up to it... that kind of information usually spreads pretty rapidly... through the compounding pharmacies themselves, they'll send out letters, and saying, hey, by the way, we have this available.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23bdd982-cd2d-4fa7-9bf1-6129983adad6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.48
      },
      "kind": "quote",
      "text": "Compounding pharmacies, that's their business. They have a vested interest in using that for this... it would be a simple email to our head of pharmacy. Tell me why we can't use a compounding pharmacy to do the same thing here.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fb39cca-7953-496f-a5f0-b93c2f613ca4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Compounding pharmacies, that’s their business. They have a vested interest in using that for this. And it’s like, oh look at that. Usually, it’s just specialty prescribing and dose limitations that we start with for an orphan drug with no other approved therapies within it...then it’s like, oh, then you have to tell us why you can’t use the compounded version [...] it would be a simple email to our head of pharmacy. Tell me why we can’t use a compounding pharmacy to do the same thing here.” — Medical director at Blue Shield of California",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ad-40c40c40f4ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f226fe2-5eb0-4576-a4f8-ff7da8ca4e8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Blue Shield stated it is simple for insurers to force patients to fill regular diazoxide at compounding pharmacies, with plenty of precedent in rare disease indications when an expensive branded drug comes out with a different formulation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91a38826-9801-4b03-9062-35b6c3add27c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "expose_contradiction",
      "slug": null,
      "matchId": "cd382373-2d6f-488b-86f3-8258efa9441f",
      "evidence": "The slide uses expert testimony to reveal the insurer's internal logic regarding cost-saving measures via compounding pharmacies.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}